Choosing Sglt2 Inhibitors Vs Glp-1 Receptor Agonists

Benefits of SGLT2 Inhibitors and GLP-1 Receptor Agonists

Harvard Medical School Continuing Education

Jeffrey Berger, MD: Deciding Between GLP1 Agonists or SGLT2 Inhibitors

Prof Melanie Davies - 'Do GLP-1 analogues and SGLT2 inhibitors have a role beyond type 2 diabetes?'

At the Limits - Leading Medical Education

Type 2 Diabetes: The Effects of Different Antidiabetic Drug Classes on Mortality

SGLT2 Inhibitors and GLP1 Receptor Agonists Reduce All-Cause Mortality Among Other Patient Benefits

Family & Community Medicine Grand Rounds

Is One SGLT2 (Or GLP-1) Just Like Another for Cardiac Benefit?

Dr Darren K. McGuire Discusses Use of SGLT2 Inhibitors and GLP-1 Receptor Agonists in T2D

EFL033 - GLP-1 Receptor Agonists and SGLT2 Inhibitors in Type 1 Diabetes

Endocrine Society

EASD 2023 - Benefits of SGLT2 inhibitors and GLP-1 receptor agonists beyond glycaemic control

European Association for the Study of Diabetes

Exploring the Science and Practice of GLP-1 Receptor Agonists

Protocols for Safe Use of SGLT2i and GLP1RA in the Hospital Setting

University of Ottawa Heart Institute

Fundamentals of SGLT2i's and GLP-1RA's for CV Risk

American College of Cardiology

Using GLP-1 Agonists & SGLT-2 Inhibitors Together from the Cardiologist's Perspective (SGLT2 & GLP1)

Robert Gabbay, MD, PhD: The Debate About SGLT-2 Inhibitors and GLP-1 Receptor Agonists

Role of GLP-1 Receptor Agonists for Weight Loss

Harvard Medical School Continuing Education

Peter Toth, MD: GLP-1 Agonists and SGLT-2 Inhibitors for Diabetes

Glucagon-like Peptide (GLP-1) - Diabetes Treatment - Semaglutide (Ozempic), (Wegovy)

Medicosis Perfectionalis

GLP 1 Receptor Agonists and DPP 4 Inhibitors Mechanism of Action

Selecting and Using a GLP-1 Agonist to Treat T2D